Emerald Advisers, LLC Exact Sciences Corp Transaction History
Emerald Advisers, LLC
- $2.23 Billion
- Q2 2024
A detailed history of Emerald Advisers, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Emerald Advisers, LLC holds 5,363 shares of EXAS stock, worth $356,210. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,363Holding current value
$356,210% of portfolio
0.01%Shares
9 transactions
Others Institutions Holding EXAS
# of Institutions
610Shares Held
166MCall Options Held
1.93MPut Options Held
1.23M-
Vanguard Group Inc Valley Forge, PA18.2MShares$1.21 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA16.5MShares$1.1 Billion0.12% of portfolio
-
Wellington Management Group LLP Boston, MA14.8MShares$982 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$801 Million0.01% of portfolio
-
State Street Corp Boston, MA8.21MShares$545 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $11.8B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...